Page 2 - Benjamin Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

After breaking her sister's 100 breast record last season, Ava Muzzy took down her Class 3 mark in the 500 free this season.

MetroHealth Cancer Center partners with The Gathering Place MetroHealth Cancer Center partners with The Gathering Place Print MetroHealth has partnered with The Gathering Place, a nonprofit organization that supports and educates individuals and families coping with the impact of cancer, to bring those support services to MetroHealth's Cancer Center two days a week, according to a news release. "We are so fortunate to have The Gathering Place in our community, an organization that is dedicated to and has the expertise in providing an incredible array of services to survivors of cancer and t...

MetroHealth forms Center for Cancer Research Print A newly formed MetroHealth Center for Cancer Research brings together nationally and internationally recognized researchers to focus on more than curing one of the most feared diseases. Backed by millions of dollars in support and grants and dozens of research assistants, the team will also focus on ending racial, ethnic, social and economic inequities that impact cancer diagnosis and treatment, according to a news release. "We're doing this for the patients we serve, to ensure that they have the latest advances in cancer care and that they a...

Italian firm brings bacterial conjunctivitis drug to Asia Italian firm brings bacterial conjunctivitis drug to Asia 18 January 2021 | News NTC014 seeks to provide physicians with rational treatment for moderate to severe bacterial conjunctivitis, a common eye infection Source credit: Shutterstock NTC, an international R&D-focused pharmaceutical company based in Italy, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, have fully integrated the ophthalmology platform with a leading foundation in eye care, announced its agreement for an exclusive license and distribution ...

NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 14/01/2021 - 11:30 '); '); MILAN, Italy and HONG KONG, Jan. 14, 2021 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered in Italy, and Zhaoke (Hong Kong) Ophthalmology Pharmaceuticals Limited, having a fully integrated ophthalmic platform with strong foundation in eyecare, announce today their agreement for exclusive license and distribution rights of NTC014, innovative fixed combination of a quinolone antibiotic and a NSAID in eye ...